These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21097732)

  • 1. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA; Friedrich D; Meier A; Corey L
    BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
    LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L;
    J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.
    Ngo TD; Laeyendecker O; La H; Hogrefe W; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2008 Feb; 15(2):382-4. PubMed ID: 18077617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
    Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
    Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
    Al-Sulaiman AM; Vallely PJ; Klapper PE
    Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.
    Binnicker MJ; Jespersen DJ; Harring JA
    Clin Vaccine Immunol; 2010 Feb; 17(2):253-7. PubMed ID: 20007366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
    Mujugira A; Morrow RA; Celum C; Lingappa J; Delany-Moretlwe S; Fife KH; Heffron R; De Bruyn G; Homawoo B; Karita E; Mugo N; Vwalika B; Baeten JM;
    Sex Transm Infect; 2011 Apr; 87(3):238-41. PubMed ID: 21307152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.
    Ramos S; Lukefahr JL; Morrow RA; Stanberry LR; Rosenthal SL
    Pediatr Infect Dis J; 2006 Oct; 25(10):902-5. PubMed ID: 17006285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
    Agyemang E; Le QA; Warren T; Magaret AS; Selke S; Johnston C; Jerome KR; Wald A
    Sex Transm Dis; 2017 Dec; 44(12):763-767. PubMed ID: 28876290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.
    Hobbs MM; Mwanyumba SW; Luseno WK; Hartman S; Halpern CT; Hallfors DD; Cho H
    Sex Transm Dis; 2017 Feb; 44(2):101-103. PubMed ID: 28081046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.
    Ngo TD; Laeyendecker O; Morrow RA; Lai S; Quinn TC
    Clin Vaccine Immunol; 2008 Aug; 15(8):1301-3. PubMed ID: 18508932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
    Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
    BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.
    Summerton J; Riedesel M; Laeyendecker O; Gaydos C; Maldeis NE; Hardick A; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2007 Dec; 14(12):1545-9. PubMed ID: 17913866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.